454 results on '"Citera,Gustavo"'
Search Results
102. Work Status Among Patients With Ankylosing Spondylitis in Argentina
103. Prevalence and Clinical Significance of Eosinophilia in Patients With Rheumatoid Arthritis in Argentina
104. Depression is a major driver of functional capacity in patients with rheumatoid arthritis regardless of disease activity
105. Una nueva herramienta para valorar la calidad de vida de pacientes con artritis reumatoidea que no requiere licencia: el cuestionario QOL-RA II (Quality of Life-Rheumatoid Arthritis Scale-II)
106. Audiovestibular Disorders in Patients With Ankylosing Spondylitis
107. Effects of Functional Electrostimulation on Pain, Muscular Strength, and Functional Capacity in Patients With Osteoarthritis of the Knee
108. Efficacy, Safety, and Immunogenicity of Biosimilar Etanercept (Enerceptan) Versus Its Original Form in Combination With Methotrexate in Patients With Rheumatoid Arthritis: A Randomized, Multicenter, Evaluator-Blinded, Noninferiority Study.
109. Depression Is a Major Determinant of Functional Capacity in Rheumatoid Arthritis.
110. Validation and Crosscultural Adaptation of an Argentine Spanish Version of the Health Assessment Questionnaire Disability Index
111. Pathological Mineralizations: Calcifications and Si-Bearing Particles in Soft Tissues and Their Eventual Relationship to Different Prostheses
112. Longterm Drug Survival of Tumor Necrosis Factor Inhibitors in Patients with Rheumatoid Arthritis
113. THU0649 PHENOTYPIC CLUSTERS OF RHEUMATIC/SYSTEMIC IMMUNE-RELATED ADVERSE EVENTS INDUCED BY CANCER IMMUNOTHERAPIES (IMMUNOCANCER INTERNATIONAL REGISTRY)
114. The Depression is a major determinant of functional capacity in patients with rheumatoid arthritis, regardless of disease activity
115. THU0628 IMMUNE-RELATED ADVERSE EVENTS INDUCED BY CANCER IMMUNOTHERAPIES. BIG DATA ANALYSIS OF 13,051 CASES (IMMUNOCANCER INTERNATIONAL REGISTRY)
116. SAT0631 CRITERION VALIDITY AND CUT-OFFS OF THE FLARE ASSESSMENT IN RHEUMATOID ARTHRITIS (FLARE-RA) QUESTIONNAIRE: INTERNATIONAL COLLABORATION
117. A new tool to assess the quality of life of patients with rheumatoid arthritis that does not require a license: the QOL-RA II (Quality Of Life-Rheumatoid Arthritis Scale-II) questionnaire
118. Three Multicenter, Randomized, Double‐Blind, Placebo‐Controlled Studies Evaluating the Efficacy and Safety of Ustekinumab in Axial Spondyloarthritis
119. Retraction Note: Quality of life of patients with rheumatoid arthritis in Argentina: reliability, validity, and sensitivity to change of a Spanish version of the Rheumatoid Arthritis Quality of Life questionnaire
120. Mycobacterium bovis and septic glenohumeral arthritis
121. Longterm Drug Survival of Tumor Necrosis Factor Inhibitors in Patients with Rheumatoid Arthritis.
122. Frequency of human leukocyte antigens class II-DR alleles (HLA-DRB1) in Argentinian patients with early arthritis
123. Validación del índice QOL-RA (Quality of Life-Rheumatoid Arthritis) en una cohorte argentina de pacientes con artritis reumatoidea
124. ¿Cuál es el verdadero rol de los ACPAs en la artritis reumatoidea?
125. Oral Abstracts 7: RA Clinical * O37. Long-Term Outcomes of Early RA Patients Initiated with Adalimumab Plus Methotrexate Compared with Methotrexate Alone Following a Targeted Treatment Approach
126. Gender differences among patients with primary ankylosing spondylitis and spondylitis associated with psoriasis and inflammatory bowel disease in an iberoamerican spondyloarthritis cohort
127. Effects of Long‐Term Etanercept Treatment on Clinical Outcomes and Objective Signs of Inflammation in Early Nonradiographic Axial Spondyloarthritis: 104‐Week Results From a Randomized, Placebo‐Controlled Study
128. La utilidad de la ultrasonografía como herramienta diagnóstica para detectar artritis psoriásica en pacientes con psoriasis
129. Impact of an Awareness Campaign for the Detection of Axial Spondyloarthritis in Patients with Inflammatory Back Pain
130. Gender differences among patients with primary ankylosing spondylitis and spondylitis associated with psoriasis and inflammatory bowel disease in an iberoamerican spondyloarthritis cohort
131. Viraje tuberculínico en pacientes con artritis inflamatorias crónicas y terapia biológica
132. Validación del cuestionario RAPID3 en la cohorte argentina ESPAXIA de pacientes con espondiloartritis axial
133. Efficacy and safety of etanercept in patients from Latin America, Central Europe and Asia with early non-radiographic axial spondyloarthritis
134. Frequency of human leukocyte antigens class II-DR alleles (HLA-DRB1) in Argentinian patients with early arthritis.
135. Three Multicenter, Randomized, Double‐Blind, Placebo‐Controlled Studies Evaluating the Efficacy and Safety of Ustekinumab in Axial Spondyloarthritis.
136. Tuberculin test conversion in patients with chronic inflammatory arthritis receiving biological therapy.
137. Tuberculin test conversion in patients with chronic inflammatory arthritis receiving biological therapy.
138. Age-based (<65 vs ≥65 years) incidence of infections and serious infections with tofacitinib versus biological DMARDs in rheumatoid arthritis clinical trials and the US Corrona RA registry.
139. Clinical responses by baseline RA disease duration in the AMPLE (abatacept versus adalimumab comparison in biologic-nave RA patients with background methotrexate) trial: 2-year results
140. Q222R polymorphism in the DNAse I gene is not associated with susceptibility to rheumatoid arthritis or to disease course in an Argentine patient cohort
141. Reductions in disease activity in the AMPLE trial: clinical response by baseline disease duration
142. Frecuencia de mortalidad en pacientes con artritis reumatoidea en un centro de reumatología de Argentina
143. Comorbidities in Argentine patients with axial spondyloarthritis: Is nephrolithiasis associated with this disease?
144. Efficacy and safety of etanercept in patients from Latin America, Central Europe and Asia with early non‐radiographic axial spondyloarthritis.
145. Clinical and MRI responses to etanercept in early non-radiographic axial spondyloarthritis: 48-week results from the EMBARK study
146. Sa1096 High Prevalence of Risk Factors for GI Adverse Effects of Non-Steroidal Anti-Inflammatory Drugs in Rheumatic Patients and Low Adherence to the Administration of Gastroprotective Agents in Latin America: Results of an Observational Study
147. Frecuencia de mortalidad en pacientes con artritis reumatoidea en un centro de reumatología de Argentina
148. Manifestaciones reumatológicas y sistémicas en pacientes con enfermedad inflamatoria intestinal
149. Certolizumab para el tratamiento de un paciente con artritis reumatoidea refractaria a múltiples agentes biológicos
150. Effects of cigarette smoking on early arthritis: a cross-sectional study—data from the Argentine Consortium for Early Arthritis (CONAART)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.